Skip to main content
SpringerLink
Log in

Intraperitoneal Chemotherapy: A Possible Role in the Treatment of Hepatic Metastases

  • Chapter
Liver Cancer

Part of the book series: Developments in Oncology ((DION,volume 30))

Abstract

In recent years there have been a number of clinical investigations utilizing intraperitoneal (IP) chemotherapy for the treatment of intracavitary and intrahepatic disease. The aim of this locoregional therapy is to provide high intratumor concentrations of antineoplastic agents while reducing the systemic exposure to these toxic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cass AW, Million RR, Pfaff WW. Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 37:2861–2865, 1976.

    Article  PubMed  CAS  Google Scholar 

  2. Dionne L. The pattern of blood-borne metastasis from carcinoma of rectum. Cancer 18:775–781, 1965.

    Article  PubMed  CAS  Google Scholar 

  3. Taylor FW. Cancer of the colon and rectum: a study of routes and metastases and death. Surgery 52:305–308, 1962.

    PubMed  CAS  Google Scholar 

  4. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Cancer 34:1278–1292, 1974.

    Article  PubMed  CAS  Google Scholar 

  5. Ackerman NB, Lien WM, Kondi ES, Silverman NA. The blood supply of experimental liver metastases. 1. The distribution of hepatic artery and portal vein blood to “small” and “large” tumors. Surgery 66:1067–1072, 1969.

    PubMed  CAS  Google Scholar 

  6. Taylor I, Bennett R, Sherriff S. The blood supply of colorectal liver metastases. Br J Cancer 39:749–756, 1979.

    Google Scholar 

  7. Taylor I. Cytotoxic perfusion for colorectal liver metastases. Br J Surg 65:109–114, 1978.

    Article  PubMed  CAS  Google Scholar 

  8. Collins JM. Pharmacokinetic rationale for intra-arterial therapy. Proceedings of Conference on Intra-arterial and Intracavitary Chemotherapy. University of Calif, San Diego, 1984.

    Google Scholar 

  9. Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Come S, Steele G, Frei E (III). A clinical-pharmacological evaluation of hepatic arterial infusions of 5-Fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res 3784–3792, 1978.

    Google Scholar 

  10. Barone RM, Byfield JE, Goldfarb PB, Frankel S, Ginn C, Greer S. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 50:850–862, 1982.

    Article  PubMed  CAS  Google Scholar 

  11. Niederhuber JE, Ensminger W, Gyves J. Thrall J, Walker S, Cozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 13336–1343, 1984.

    Google Scholar 

  12. Lewis BJ. Intra-arterial versus intravenous FudR for colorectal cancer metastatic to the liver: a Northern California Oncology Group study. Proceedings of Conference on Intra-arterial and Intracavity Chemotherapy—University of California at San Diego, 1984.

    Google Scholar 

  13. Kemeny N. Randomized study of intra-arterial versus systemic infusion of flurodeoxyuridine inpatients with liver metastases from colorectal carcinoma. Proceedings of Conference on Intraarterial and Intracavity Chemotherapy—University of California at San Diego, 1984.

    Google Scholar 

  14. Collins JM, Dedrick RL, King FG, Speyer JL, Myers CE. Nonlinear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitoneal routes. Clin Pharmac and Therap 25:235–246, 1980.

    Article  Google Scholar 

  15. Taylor I, Brooman P, Rowling JT. Adjuvant liver perfusion in colorectal cancer: initial results of a clinical trial. Br Med J 2:1320–1322, 1977.

    Article  PubMed  CAS  Google Scholar 

  16. Almersjo O, Gustavsson B, Hafstrom L. Results of regional portal infusion of 5-Fluorouracil in patients with primary and secondary liver cancer. Annales Chirurgiae et Gynaecologiea 65:27–32, 1976.

    Google Scholar 

  17. Kaplan WE, Ensminger WD, Come SE, Smith EH, D’Orsl CJ, Levin DC, Takvonan RW, Steele GD. Radionuclide angiography to predict patient response to hepatic artery chemotherapy. Cancer Treat Rep 64:1217–1222, 1980.

    PubMed  CAS  Google Scholar 

  18. Barone RM. Technical aspects of arterial access and contrast infusion. Proceedings of Conference on Intra-arterial and Intra-cavity Chemotherapy—University of California at San Diego, 1984.

    Google Scholar 

  19. Kaplan WD, O’Orsl CJ, Ensminger WD, et al. Intra-arterial radionuclide infusion: a new technique to assess chemotherapy perfusion patterns. Cancer Treat Rep 62:669, 1978.

    Google Scholar 

  20. Goldman ML, Bilbao MK, Rosch J, Dotter CT. Complications of indwelling chemotherapy catheters. Cancer 36:1983–1990, 1975.

    Article  PubMed  CAS  Google Scholar 

  21. Fortner JG, Pahnke LD. A new method for long term intra-hepatic chemotherapy. Surg Gynecol Obstet 143:979–980, 1976.

    PubMed  CAS  Google Scholar 

  22. Ensminger W, Niederhuber J. Dakhil S. Thrall J, Wheeler R. Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 65:393–400, 1981.

    PubMed  CAS  Google Scholar 

  23. Speyer TL, Myers CE. Intraperitoneal chemotherapy of ovarian cancer. In Recent Advances in Clinical Oncology, William CJ, Whitehouse JMA (eds). Edinburgh: Churchill Livingstone, 1982.

    Google Scholar 

  24. Dedrick RL, Myers CE, Bungay PM, DeVita VT (Jr). Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62:1–11, 1978.

    PubMed  CAS  Google Scholar 

  25. Torres IG, Litterst CL, Guarino AM. Transport of model compounds across the peritoneal membrane in the rat. Pharmac 17:330–340, 1978.

    CAS  Google Scholar 

  26. Jones RB, Collins JM, Myers CE, et al. High volume intraperitoneal chemotherapy with methotrexate in patients with cancer. Cancer Res 41:55–59, 1981.

    PubMed  CAS  Google Scholar 

  27. Speyer JL, Collins JM, Dedrick RL, Brennan MF, Londer H, DeVita VT, Myers CE. Phase I and pharmacologic studies of intraperitoneal 5-fluorouracil. Cancer Res 40:567–572, 1980.

    PubMed  CAS  Google Scholar 

  28. Ozols RF, Young RC, Speyer JL, Sugarbaker PH, Green R, Jenkins J, Myers CE. Phase I and pharmacologic studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 42:4265–269, 1982.

    PubMed  CAS  Google Scholar 

  29. Howell SB, Pfeifle CL, Wung WE, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Int Med 77:845–851, 1982.

    Google Scholar 

  30. Howell SB. Phase I trials and pharmacokinetics of intraperitoneal cisplatinum, melphalan and cytarabine. Proceedings of Conference on Intra-arterial and Intracavity Chemotherapy—University of California at San Diego, 1984.

    Google Scholar 

  31. Markman M. Bleomycin. Personal communication.

    Google Scholar 

  32. Bast RC, Berek SS, Obrist R, et al. Intraperitoneal immunotherapy of human ovarian carcinoma with corynebacterium Parvum. Cancer Res 43:1395–1401, 1983.

    PubMed  Google Scholar 

  33. Spiegel R. Personal communication.

    Google Scholar 

  34. Speyer JL, Sugarbaker PH, Collins JM, Dedrick RL, Klecker RW (Jr), Myers CE. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in man. Cancer Res 41:1916–1922, 1982.

    Google Scholar 

  35. Christophidis N, Vajda JFE, Lucas I, Drummer O, Moon WJ, Louis WJ. Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration. Clin Pharmacokinetics 3:330–335, 1978.

    Article  Google Scholar 

  36. MacMillan WE, Wolberg WH, Welling PG. Pharmacokinetics of fluorouracil in humans. Cancer Res 38:3479–3482, 1978.

    PubMed  CAS  Google Scholar 

  37. Hillcoat BL, McCulloch PB, Figueroedo AT, Ehsan MH, Rosenfeld JM. Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion. Br J Cancer 38:719–724, 1978.

    Article  PubMed  CAS  Google Scholar 

  38. Sugarbaker P. Personal communication.

    Google Scholar 

  39. Jenkins JF, Sugarbaker DH, Gianoa FJ, Myers CE. Technical consideration in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. Surg Gynecol Obstet 154:858–864, 1982.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. James L. Speyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rita and Stanley H. Kaplan Cancer Center, New York University Medical Center, 550 First Avenue, New York, NY, 10016, USA

    Joseph C. Bottino M.D.  & Franco M. Muggia M.D.  & 

  2. Clinical Oncology Program, University of California,Irvine Medical Center, Orange, CA, 92668, USA

    Richard W. Opfell M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishing, Boston/Dordrecht/Lancaster

About this chapter

Cite this chapter

Speyer, J.L. (1985). Intraperitoneal Chemotherapy: A Possible Role in the Treatment of Hepatic Metastases. In: Bottino, J.C., Opfell, R.W., Muggia, F.M. (eds) Liver Cancer. Developments in Oncology, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2593-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2593-2_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9625-6

  • Online ISBN: 978-1-4613-2593-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation